News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
116,342 Results
Type
Article (4081)
Company Profile (10)
Press Release (112250)
Section
Business (43304)
Career Advice (139)
Deals (7323)
Drug Delivery (8)
Drug Development (13285)
Employer Resources (19)
FDA (2531)
Job Trends (2662)
News (60653)
Policy (4552)
Tag
2027 BioCapital Standard (1)
2027 Biotech Beach Elite (1)
Academia (233)
Accelerated approval (19)
ADA (12)
Adcomms (1)
Allergies (47)
Alliances (4838)
ALS (49)
Alzheimer's disease (406)
Antibody-drug conjugate (ADC) (153)
Approvals (2800)
Artificial intelligence (131)
ASCO (84)
Autoimmune disease (79)
Automation (13)
Bankruptcy (40)
Belgium (2)
Best Places to Work (2389)
BIO (7)
Biologics (2)
BIOSECURE Act (3)
Biosimilars (37)
BioSpace Insights (11)
Biotechnology (13)
Bladder cancer (70)
Brain cancer (22)
Breast cancer (211)
Cancer (1724)
Cardiovascular disease (136)
Career advice (119)
Career pathing (3)
CAR-T (52)
CDC (9)
CDMO (12)
Celiac Disease (2)
Cell therapy (167)
Cervical cancer (20)
Clinical research (13135)
Collaboration (321)
Commercialization (3)
Compensation (230)
Complete response letters (21)
COVID-19 (340)
CRISPR (17)
C-suite (171)
Cystic fibrosis (24)
Data (2772)
Denatured (2)
Depression (54)
Dermatology (34)
Diabetes (120)
Diagnostics (1396)
Digital health (15)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (42)
Drug pricing (20)
Drug shortages (2)
Duchenne muscular dystrophy (65)
Earnings (32326)
Editorial (9)
Employer branding (8)
Employer resources (17)
Events (18128)
Executive appointments (143)
FDA (3754)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (16)
Funding (257)
Gene editing (37)
Generative AI (14)
Gene therapy (118)
GLP-1 (244)
Government (584)
Grass and pollen (1)
Guidances (279)
Healthcare (3217)
Hematology (54)
HIV (21)
Huntington's disease (13)
IgA nephropathy (35)
Immunology and inflammation (35)
Immuno-oncology (20)
Indications (70)
Infectious disease (427)
Inflammatory bowel disease (35)
Inflation Reduction Act (2)
Influenza (42)
Intellectual property (74)
Interviews (19)
IPO (4730)
IRA (1)
Job creations (352)
Job search strategy (107)
JPM (5)
Kidney cancer (6)
Kidney disease (8)
Labor market (26)
Layoffs (84)
Leadership (3)
Legal (893)
Licensing (6)
Liver cancer (21)
Longevity (8)
Lung cancer (282)
Lymphoma (154)
Machine learning (12)
Management (6)
Manufacturing (186)
Marketing (4)
MASH (62)
Medical affairs (1)
Medical device (2776)
Medtech (2826)
Mergers & acquisitions (2975)
Metabolic disorders (390)
mRNA (18)
Multiple sclerosis (48)
NASH (4)
Netherlands (2)
Neurodegenerative disease (88)
Neuropsychiatric disorders (19)
Neuroscience (796)
NextGen: Class of 2026 (830)
Non-profit (524)
Now hiring (6)
Obesity (193)
Opinion (24)
Ovarian cancer (59)
Pain (48)
Pancreatic cancer (89)
Parkinson's disease (76)
Partnered (5)
Patents (157)
Patient recruitment (129)
Patient selection (2)
Peanut (16)
People (5382)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (6)
Phase 1 (3520)
Phase 2 (5575)
Phase 3 (5098)
Pipeline (4120)
Policy (38)
Postmarket research (454)
Preclinical (1275)
Press Release (11)
Prostate cancer (78)
Psychedelics (6)
Radiopharmaceuticals (68)
Rare diseases (232)
Real estate (520)
Recruiting (8)
Regulatory (4437)
Reports (17)
Research institute (224)
Resumes & cover letters (20)
Rett syndrome (7)
RNA editing (4)
RSV (24)
Schizophrenia (60)
Series A (33)
Series B (29)
Sickle cell disease (24)
Special edition (9)
Spinal muscular atrophy (24)
Sponsored (6)
Startups (255)
Stomach cancer (1)
Supply chain (18)
Tariffs (33)
The Weekly (8)
Vaccines (173)
Venture capital (15)
Weight loss (122)
Women's health (20)
Worklife (1)
Date
Today (31)
Last 7 days (106)
Last 30 days (513)
Last 365 days (7433)
2026 (5565)
2025 (7663)
2024 (7905)
2023 (8957)
2022 (9080)
2021 (9508)
2020 (9490)
2019 (6883)
2018 (5365)
2017 (5351)
2016 (4103)
2015 (5621)
2014 (3612)
2013 (2521)
2012 (3191)
2011 (3465)
2010 (3002)
Location
Africa (88)
Alabama (20)
Arizona (90)
Arkansas (1)
Asia (6537)
Australia (1077)
California (3828)
Canada (821)
China (347)
Colorado (222)
Connecticut (247)
Delaware (179)
Europe (15744)
Florida (677)
Georgia (134)
Hawaii (2)
Idaho (9)
Illinois (345)
India (26)
Indiana (248)
Japan (155)
Kansas (67)
Kentucky (12)
Louisiana (19)
Maine (24)
Maryland (448)
Massachusetts (2252)
Michigan (113)
Minnesota (149)
Missouri (34)
Montana (5)
Nebraska (2)
Nevada (34)
New Hampshire (13)
New Jersey (1177)
New Mexico (6)
New York (1013)
North Carolina (366)
North Dakota (1)
Northern California (2063)
Ohio (105)
Oklahoma (3)
Oregon (3)
Pennsylvania (725)
Puerto Rico (4)
Rhode Island (8)
South America (154)
South Carolina (10)
Southern California (1533)
Tennessee (42)
Texas (711)
United States (13436)
Utah (121)
Vermont (1)
Virginia (87)
Washington D.C. (14)
Washington State (285)
West Virginia (1)
Wisconsin (16)
116,342 Results for "27".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
ADC Therapeutics lays off staff after 27 patient deaths mar Zynlonta readout
After 27 deaths were reported in a group receiving its blood cancer drug, ADC Therapeutics is downsizing, implementing layoffs for about 30 workers.
June 24, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
August 18, 2026
·
5 min read
Press Releases
Artelo Biosciences Announces Reverse Stock Split - August 27, 2026
August 27, 2026
·
3 min read
Press Releases
Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings
September 23, 2026
·
8 min read
Press Releases
Verrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital
August 7, 2026
·
7 min read
autoimmune disease
Amgen asset from $27.8B Horizon buy scores in Phase 3 Sjögren’s study
Amgen is awaiting another Phase 3 readout for the investigational Sjögren’s disease therapy, set for later this year. William Blair anticipates that at least two trials will be needed to support an FDA application.
September 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Secretome Therapeutics Announces Participation in Upcoming Investor Conferences - August 27, 2026
August 27, 2026
·
1 min read
Press Releases
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units
September 13, 2026
·
8 min read
Press Releases
Stonegate Updates Coverage on Burcon Nutrascience Corporation (BU) 1Q27
August 14, 2026
·
1 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - July 27, 2026
July 27, 2026
·
1 min read
1 of 11,635
Next
